Skip to main content
Log in

Costs of CDC's colorectal cancer screening demonstration program

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The CRCDP was undertaken at five sites: Baltimore City (Baltimore City Colon Cancer Screening Program); St. Louis (Missouri Screen for Life); Nebraska (Nebraska Colon Cancer Screening Program); Suffolk County, New York (Project Suffolk County Preventive Endoscopy Project [SCOPE]); and Greater Seattle (Washington Colon Health Program).

  2. faecal occult blood tests

References

  1. Subramanian S, et al. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer 119 (Suppl. 15): 2855-62, Aug 2013. Available from: URL: http://dx.doi.org/10.1002/cncr.28158.

    PubMed  Google Scholar 

  2. Tangka FK, et al. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer 119 (Suppl. 15): 2863-9, Aug 2013. Available from: URL: http://dx.doi.org/10.1002/cncr.28154.

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costs of CDC's colorectal cancer screening demonstration program. PharmacoEcon Outcomes News 684, 5 (2013). https://doi.org/10.1007/s40274-013-0605-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0605-1

Navigation